000 01093 a2200349 4500
005 20250514140628.0
264 0 _c19961201
008 199612s 0 0 eng d
022 _a0010-440X
024 7 _a10.1016/s0010-440x(64)80031-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKURLAND, A A
245 0 0 _aTHE BUTYROPHENONES IN THE TREATMENT OF THE PSYCHOTIC PATIENT.
_h[electronic resource]
260 _bComprehensive psychiatry
_cJun 1964
300 _a179-90 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomedical Research
650 0 4 _aButyrophenones
650 0 4 _aCatatonia
650 0 4 _aHaloperidol
650 0 4 _aHumans
650 0 4 _aMeperidine
650 0 4 _aParanoid Disorders
650 0 4 _aPsychotic Disorders
650 0 4 _aSchizophrenia
650 0 4 _aToxicology
650 0 4 _aTranquilizing Agents
700 1 _aFERRO-DIAZ, P
700 1 _aMCCUSKER, K
773 0 _tComprehensive psychiatry
_gvol. 5
_gp. 179-90
856 4 0 _uhttps://doi.org/10.1016/s0010-440x(64)80031-6
_zAvailable from publisher's website
999 _c13918912
_d13918912